Compare VCTR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCTR | TFX |
|---|---|---|
| Founded | 2013 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.8B |
| IPO Year | 2018 | 1994 |
| Metric | VCTR | TFX |
|---|---|---|
| Price | $107.12 | $122.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $74.44 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 627.5K | 585.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.60% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.01 | 2.08 |
| Revenue | $413,412,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $17.68 | $15.97 |
| Revenue Next Year | $5.92 | $5.15 |
| P/E Ratio | ★ $35.04 | $60.05 |
| Revenue Growth | ★ 0.92 | N/A |
| 52 Week Low | $57.03 | $100.18 |
| 52 Week High | $123.55 | $145.00 |
| Indicator | VCTR | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 27.56 |
| Support Level | $101.40 | $119.69 |
| Resistance Level | $119.56 | $137.48 |
| Average True Range (ATR) | 3.51 | 3.55 |
| MACD | -1.18 | -1.28 |
| Stochastic Oscillator | 18.35 | 2.23 |
Victory Capital Holdings Inc is a diversified investment management firm. The company provides specialized investment strategies to institutions, intermediaries, retirement platforms and individual investors. Its offerings include actively and passively managed mutual funds, rules-based and active exchange traded funds (ETFs), institutional separate accounts, variable insurance products (VIPs), alternative investments, private closed end funds, and a 529 Education Savings Plan. The company operates in one operating and reportable segment that provides investment management services and products to institutional, intermediary, retirement platforms and individual investors. The majority of the company's revenue consists of Investment management fees.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.